IL3 and hepatocellular carcinoma: Additionally, hsa-miR-219-5p was found to be regulated by IL-3, GM-CSF and G-CSF in acute myeloid leukaemia6, and it inhibits HCC cell proliferation through cell cycle arrest by targeting glypican-328.